Tradename | Company | Number | Date | Products |
---|---|---|---|---|
DORMATE | Medpointe Pharm Hlc | N-017374 DISCN | 1982-01-01 | 1 products |
Brand Name | Status | Last Update |
---|---|---|
2xl mega roll sanitizing wipes 2300 count megaroll | OTC monograph not final | 2022-11-29 |
2xl mega rolls sanitizing wipes | C200263 | 2024-12-06 |
bain de soleil | OTC monograph final | 2023-09-08 |
cablivi | Biologic Licensing Application | 2024-11-04 |
cellbn mega plus | unapproved drug other | 2017-05-29 |
dr andrew weils for origins | C200263 | 2023-09-11 |
dr weils mega-defense advanced daily uv defender broad spectrum spf 45 | OTC monograph not final | 2021-07-14 |
dr. andrew weil for origins | C200263 | 2024-12-25 |
jba verestor mega fiber caffe latte | unapproved drug other | 2024-11-11 |
jba verestor mega fiber powder | unapproved drug other | 2024-11-11 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Obesity | D009765 | EFO_0001073 | E66.9 | — | 1 | — | 1 | 7 | 9 |
Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | 1 | 1 | — | 1 | 4 | 7 |
Insulin resistance | D007333 | EFO_0002614 | E88.819 | — | — | 1 | 1 | 3 | 5 |
Critical illness | D016638 | — | — | — | — | — | 1 | 3 | 4 |
Chronic obstructive pulmonary disease | D029424 | EFO_0000341 | J44.9 | — | — | 2 | 1 | 1 | 4 |
Resistance training | D055070 | — | — | — | — | — | 1 | 3 | 4 |
Myofascial pain syndromes | D009209 | EFO_1001054 | — | — | — | — | 1 | 3 | 4 |
Fibromyalgia | D005356 | EFO_0005687 | M79.1 | — | — | — | 1 | 3 | 4 |
Lung diseases | D008171 | EFO_0003818 | J98.4 | — | — | 1 | 1 | 1 | 3 |
Obstructive lung diseases | D008173 | — | — | — | — | 2 | 1 | — | 3 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Neoplasms | D009369 | — | C80 | 1 | 3 | 1 | — | 2 | 6 |
Leukemia | D007938 | — | C95 | — | 2 | 3 | — | — | 4 |
Precursor cell lymphoblastic leukemia-lymphoma | D054198 | — | C91.0 | — | 2 | 3 | — | — | 4 |
Lymphoid leukemia | D007945 | — | C91 | — | 2 | 3 | — | — | 4 |
Prostatic neoplasms | D011471 | — | C61 | 1 | 3 | 2 | — | — | 4 |
Anxiety disorders | D001008 | EFO_0006788 | F41.1 | — | — | 1 | — | 3 | 4 |
Attention deficit disorder with hyperactivity | D001289 | EFO_0003888 | F90 | — | — | 1 | — | 3 | 4 |
Precursor t-cell lymphoblastic leukemia-lymphoma | D054218 | — | — | — | 1 | 2 | — | — | 3 |
Lymphoma | D008223 | — | C85.9 | — | — | 2 | — | 1 | 3 |
Dyslipidemias | D050171 | — | — | — | — | 1 | — | 2 | 3 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Syndrome | D013577 | — | — | — | 2 | — | — | 7 | 9 |
Sleep initiation and maintenance disorders | D007319 | — | F51.01 | — | 1 | — | — | 4 | 5 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | — | 1 | — | — | 2 | 3 |
Carcinoma | D002277 | — | C80.0 | 1 | 2 | — | — | 1 | 3 |
Anemia | D000740 | EFO_0004272 | D64.9 | 1 | 1 | — | — | 1 | 3 |
Cognitive dysfunction | D060825 | — | G31.84 | — | 1 | — | — | 2 | 3 |
Esophageal neoplasms | D004938 | — | C15 | — | 2 | — | — | — | 2 |
Hematologic neoplasms | D019337 | — | — | 1 | 1 | — | — | 1 | 2 |
Memory | D008568 | — | — | — | 1 | — | — | 1 | 2 |
Blastic plasmacytoid dendritic cell neoplasm | D000099067 | — | C86.4 | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 1 | — | — | — | 6 | 7 |
Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | 1 | — | — | — | 4 | 5 |
Depression | D003863 | — | F33.9 | 1 | — | — | — | 4 | 5 |
Glioma | D005910 | EFO_0000520 | — | 1 | — | — | — | 4 | 5 |
Depressive disorder | D003866 | EFO_1002014 | F32.A | 1 | — | — | — | 4 | 5 |
Transcranial magnetic stimulation | D050781 | — | — | 1 | — | — | — | 1 | 2 |
Glioblastoma | D005909 | EFO_0000515 | — | 1 | — | — | — | 1 | 2 |
Fanconi anemia | D005199 | Orphanet_84 | D61.03 | 1 | — | — | — | — | 1 |
Fanconi syndrome | D005198 | — | — | 1 | — | — | — | — | 1 |
Neuronal plasticity | D009473 | — | — | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Exercise | D015444 | EFO_0000483 | — | — | — | — | — | 8 | 8 |
Dental caries | D003731 | EFO_0003819 | K02 | — | — | — | — | 8 | 8 |
Osteoarthritis | D010003 | EFO_0002506 | M15-M19 | — | — | — | — | 7 | 7 |
Covid-19 | D000086382 | — | U07.1 | — | — | — | — | 6 | 6 |
Overweight | D050177 | — | E66.3 | — | — | — | — | 5 | 5 |
Postoperative pain | D010149 | — | G89.18 | — | — | — | — | 5 | 5 |
Psychomotor agitation | D011595 | — | — | — | — | — | — | 4 | 4 |
Aging | D000375 | GO_0007568 | R41.81 | — | — | — | — | 4 | 4 |
Mental disorders | D001523 | EFO_0000677 | F91.9 | — | — | — | — | 4 | 4 |
Hip osteoarthritis | D015207 | EFO_1000786 | M16 | — | — | — | — | 4 | 4 |
Drug common name | Mebutamate |
INN | mebutamate |
Description | Mebutamate (Capla, Dormate) is an anxiolytic and sedative drug with antihypertensive effects of the carbamate class. It has effects comparable to those of barbiturates such as secobarbital, but is only around 1/3 the potency of secobarbital as a sedative. Side effects include dizziness and headaches.
|
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | CCC(C)C(C)(COC(N)=O)COC(N)=O |
PDB | — |
CAS-ID | 64-55-1 |
RxCUI | — |
ChEMBL ID | CHEMBL1200922 |
ChEBI ID | — |
PubChem CID | 6151 |
DrugBank | — |
UNII ID | 5H8F175RER (ChemIDplus, GSRS) |